FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295899644> ?p ?o ?g. }

• W4295899644 abstract "Combined therapies involve the use of multiple drugs to increase efficacy and reduce the toxicity of individual treatments. We evaluated the use of combinations of conventional systemic therapies and biologics in children with psoriasis in daily practice. This two-part study used data from the 170 children in the Franco-Italian BiPe cohorts to evaluate the use, efficacy, and safety of combined conventional systemic-biologic therapies, and from a survey carried out among French and Italian dermatologists to better understand the reasons for using or avoiding these combinations. In total, 33 children (19.4%) from 13 dermatology centers received 48 combined conventional systemic-biologic therapies (cumulative duration: 43.6 years), including three triple combination therapies (acitretin-methotrexate, with a TNF-alpha inhibitor). A total of 14 different combinations were used, most frequently etanercept-acitretin (n = 10), adalimumab-acitretin (n = 7), adalimumab-methotrexate (n = 5), and ustekinumab-methotrexate (n = 5). The combined therapies were started at biologic initiation in 41 cases (85.4%), and after a period of biologic monotherapy in the remaining 7 cases. Mean PGA and PASI scores decreased between baseline and M3 with all the combinations used. Four serious adverse events were reported, all with favorable outcomes. The survey was completed by 61 dermatologists: 39 (63.9%) had previously used or planned to use the combined therapies, most commonly TNF-alpha inhibitors with acitretin or methotrexate. The main reason for using these treatments was to improve the outcome of biologic therapies in cases of partial efficacy or loss of efficacy. Combined therapies have been used frequently in the treatment of childhood psoriasis, in a range of clinical situations and in variable drug combinations, without significant toxicity. Although the use of these combined therapies needs to be clarified in future management guidelines, these combined therapies should be considered for the treatment of children with severe psoriasis, psoriatic arthritis, and recalcitrant disease." @default.
• W4295899644 created "2022-09-16" @default.
• W4295899644 creator A5002722711 @default.
• W4295899644 creator A5007427635 @default.
• W4295899644 creator A5029264492 @default.
• W4295899644 creator A5036766007 @default.
• W4295899644 creator A5040704268 @default.
• W4295899644 creator A5042438814 @default.
• W4295899644 creator A5057592368 @default.
• W4295899644 creator A5065380648 @default.
• W4295899644 creator A5070486024 @default.
• W4295899644 creator A5070891784 @default.
• W4295899644 creator A5073030919 @default.
• W4295899644 creator A5076340431 @default.
• W4295899644 creator A5076354395 @default.
• W4295899644 creator A5077954088 @default.
• W4295899644 creator A5080644245 @default.
• W4295899644 creator A5081205053 @default.
• W4295899644 creator A5084676682 @default.
• W4295899644 creator A5056789408 @default.
• W4295899644 date "2022-09-22" @default.
• W4295899644 modified "2023-10-18" @default.
• W4295899644 title "Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real‐life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists" @default.
• W4295899644 cites W1591809044 @default.
• W4295899644 cites W1842534514 @default.
• W4295899644 cites W1964871328 @default.
• W4295899644 cites W1967908624 @default.
• W4295899644 cites W2014217947 @default.
• W4295899644 cites W2029474929 @default.
• W4295899644 cites W2038348762 @default.
• W4295899644 cites W2052065030 @default.
• W4295899644 cites W2064511762 @default.
• W4295899644 cites W2069664940 @default.
• W4295899644 cites W2083502021 @default.
• W4295899644 cites W2115041506 @default.
• W4295899644 cites W2120169814 @default.
• W4295899644 cites W2156239059 @default.
• W4295899644 cites W2166199216 @default.
• W4295899644 cites W2168503185 @default.
• W4295899644 cites W2188451419 @default.
• W4295899644 cites W2506995112 @default.
• W4295899644 cites W2533501141 @default.
• W4295899644 cites W2550960301 @default.
• W4295899644 cites W2593360712 @default.
• W4295899644 cites W2606632445 @default.
• W4295899644 cites W2608059792 @default.
• W4295899644 cites W2610923037 @default.
• W4295899644 cites W2626024150 @default.
• W4295899644 cites W2742327492 @default.
• W4295899644 cites W2750210166 @default.
• W4295899644 cites W2754677541 @default.
• W4295899644 cites W2756003268 @default.
• W4295899644 cites W2793333272 @default.
• W4295899644 cites W2900115997 @default.
• W4295899644 cites W2902891962 @default.
• W4295899644 cites W2912736897 @default.
• W4295899644 cites W2924416972 @default.
• W4295899644 cites W2937096135 @default.
• W4295899644 cites W2943922930 @default.
• W4295899644 cites W2947875381 @default.
• W4295899644 cites W2973691027 @default.
• W4295899644 cites W2985156506 @default.
• W4295899644 cites W2985758722 @default.
• W4295899644 cites W3004911684 @default.
• W4295899644 cites W3092915044 @default.
• W4295899644 cites W3135499750 @default.
• W4295899644 cites W3195950510 @default.
• W4295899644 cites W3216894641 @default.
• W4295899644 cites W4200131355 @default.
• W4295899644 cites W4205485843 @default.
• W4295899644 cites W4223475670 @default.
• W4295899644 cites W4224256728 @default.
• W4295899644 doi "https://doi.org/10.1111/dth.15828" @default.
• W4295899644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36107157" @default.
• W4295899644 hasPublicationYear "2022" @default.
• W4295899644 type Work @default.
• W4295899644 citedByCount "2" @default.
• W4295899644 countsByYear W42958996442023 @default.
• W4295899644 crossrefType "journal-article" @default.
• W4295899644 hasAuthorship W4295899644A5002722711 @default.
• W4295899644 hasAuthorship W4295899644A5007427635 @default.
• W4295899644 hasAuthorship W4295899644A5029264492 @default.
• W4295899644 hasAuthorship W4295899644A5036766007 @default.
• W4295899644 hasAuthorship W4295899644A5040704268 @default.
• W4295899644 hasAuthorship W4295899644A5042438814 @default.
• W4295899644 hasAuthorship W4295899644A5056789408 @default.
• W4295899644 hasAuthorship W4295899644A5057592368 @default.
• W4295899644 hasAuthorship W4295899644A5065380648 @default.
• W4295899644 hasAuthorship W4295899644A5070486024 @default.
• W4295899644 hasAuthorship W4295899644A5070891784 @default.
• W4295899644 hasAuthorship W4295899644A5073030919 @default.
• W4295899644 hasAuthorship W4295899644A5076340431 @default.
• W4295899644 hasAuthorship W4295899644A5076354395 @default.
• W4295899644 hasAuthorship W4295899644A5077954088 @default.
• W4295899644 hasAuthorship W4295899644A5080644245 @default.
• W4295899644 hasAuthorship W4295899644A5081205053 @default.
• W4295899644 hasAuthorship W4295899644A5084676682 @default.
• W4295899644 hasConcept C126322002 @default.
• W4295899644 hasConcept C16005928 @default.
• W4295899644 hasConcept C17991360 @default.

• next